Drug induced pseudolymphoma.
Magro CM, Daniels BH, Crowson AN.
Semin Diagn Pathol. 2018 Jul;35(4):247-259. doi: 10.1053/j.semdp.2017.11.003. Epub 2018 Feb 1.
Drug-induced cutaneous pseudolymphoma: A systematic review of the literature.
Etesami I, Kalantari Y, Tavakolpour S, Mahmoudi H, Daneshpazhooh M.
Australas J Dermatol. 2023 Feb;64(1):41-49. doi: 10.1111/ajd.13951. Epub 2022 Nov 4.
Severe drug-induced dermatoses.
Ahronowitz I, Fox L.
Semin Cutan Med Surg. 2014 Mar;33(1):49-58. doi: 10.12788/j.sder.0062.
Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).
Bocquet H, Bagot M, Roujeau JC.
Semin Cutan Med Surg. 1996 Dec;15(4):250-7. doi: 10.1016/s1085-5629(96)80038-1.
Drug-induced pseudolymphoma syndrome.
Mittal RR, Jain C, Walia RL, Chopra A.
Indian J Dermatol Venereol Leprol. 1995 Mar-Apr;61(2):94-5.
Drug-induced CD30+ T cell pseudolymphoma.
Fukamachi S, Sugita K, Sawada Y, Bito T, Nakamura M, Tokura Y.
Eur J Dermatol. 2009 May-Jun;19(3):292-4. doi: 10.1684/ejd.2009.0667. Epub 2009 Mar 31.
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities.
Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P, Morel P, Dubertret L, Avril MF, Revuz J.
Arch Dermatol. 1996 Nov;132(11):1315-21.
Cutaneous targets in drug-induced reactions.
Filotico R, Mastrandrea V.
G Ital Dermatol Venereol. 2014 Apr;149(2):227-35.
Drug induced pseudolymphoma secondary to ethosuximide.
Masruha MR, Marques CM, Vilanova LC, de Seixas Alves MT, Peres MF, Rodrigues MG.
J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1610. doi: 10.1136/jnnp.2005.064923.
[Drug-induced pseudolymphoma].
Olmos L, Laugier P.
Rev Clin Esp. 1980 Apr 15;157(1):67-70.
